Stockscreener 앱 받기
5.73
20.13%
0.96
시간 외 거래:
5.68
-0.05
-0.87%
전일 마감가:
$4.77
열려 있는:
$4.77
하루 거래량:
653.27K
Relative Volume:
2.02
시가총액:
$405.93M
수익:
-
순이익/손실:
$-2.97M
주가수익비율:
-5.7996
EPS:
-0.988
순현금흐름:
$-1.18M
1주 성능:
+79.62%
1개월 성능:
+22.44%
6개월 성능:
-25.20%
1년 성능:
-59.78%
1일 변동 폭
$4.5475
$5.88
1주일 범위
$2.4201
$5.88
52주 변동 폭
$1.70
$22.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
5.73 | 405.93M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Yd Bio Ltd 주식(YDES)의 최신 뉴스
Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday - Benzinga
Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower I - Benzinga
US Stock Market Trends: Updated Data Analysis & Real-Time Quotes - TradingKey
Keep an eye on the top gainers and losers in Thursday's session. - ChartMill
Unusual Volume Scan: Recent Session US Stock Movers Above 50-Day Average Volume - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
Enterprise value to revenue forward of YD Bio Limited – BOATS:YDESW - TradingView
Unusual volume stocks in Tuesday's session - ChartMill
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
YD Bio Limited H1 2026 Earnings: Revenue Soars 315% to $0.85M as Warrant Revaluation Drives $6.70M Profit - technotrenz.com
YD Bio posts $6.7M profit but flags going concern | YDES SEC FilingForm 6-K - Stock Titan
YD Bio (YDES) Earnings Date and Reports 2026 - marketbeat.com
YD Bio H1FY26 Results: Revenue up 315%, net profit turns positive - scanx.trade
YD Bio Limited Reports First-Half 2026 Financial Results, 315% Revenue Growth and Net Income of $6.7 Million - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
YD Bio Limited (YDES) Edges Lower to $4.60 as Biotech Pullback Tests Key Support ZoneVolatility Smirk - dars.gov.et
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute - Yahoo Finance
YD (YDESW) Watch: Adds 10.81% to Close at $0.41; the Near-Term Reference Band Stretches From $0.39 to $0.43 in the Current UpdateMoving Average Ribbon - vinanet.vn
YD (YDES) Watch: Retreats 2.00% to $4.69; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Current UpdateDealer Positioning - vinanet.vn
Concorde (CIGL) Technicals: Slides 5.42% to $0.44 for the Current Session; Current Setup: Traders Can Monitor the $0.42-$0.46 Range in Latest TradingValue Area High - careplusvn.com
ETFs Investing in YD Bio Limited Stocks - TradingView
Top movers in Tuesday's pre-market session - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day - RTTNews
YD Bio Limited (YDES) Surges 13% as Shares Push Toward Key ResistancePCR Divergence - vinanet.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
YD Bio Launches Physician-Led Nutraceuticals in Taiwan to Build Consumer Health Ecosystem - TipRanks
YD Bio launches nutrition products via physician partnership model By Investing.com - Investing.com Australia
YD Bio launches nutrition products via physician partnership model - Investing.com
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute - Yahoo Finance
Two New Nutrition Formulas Bring YD Bio Into Taiwan Physician Network - Stock Titan
Top YD Bio (YDES) Competitors 2026 - MarketBeat
YD Bio Ord Shs (YDES) Stock News Today - TradingKey
Lantheus Holdings (LNTH) Holds Near $101 as Buyers Defend Key SupportForce Index - vinanet.vn
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research - Yahoo Finance
YD Bio Limited (YDES) Holds Steady at $2.31 — Key Support and Resistance in FocusInstitutional Buy Signals - vinanet.vn
YD Bio (YDES) Insider Trading Activity 2026 - marketbeat.com
YD Bio Launches Cross-Border Cancer Testing Pilot in Canada - Clinical Lab Products
YD Bio Warrants (YDESW) Hold Steady at $0.25 as Tight Range Caps GainsBullish Sentiment - vinanet.vn
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada - The Manila Times
YD Bio launches pilot for cancer testing in British Columbia By Investing.com - Investing.com Canada
Five Cancer Types Targeted in YD Bio's Cross-Border Pilot - Stock Titan
Y.D. More group (TATT) reports 5.42% beneficial stake in TAT Technologies - Stock Titan
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Cash Flow - TradingKey
YDES|YD Bio Ord Shs|Price:2.350|Chg%:+0.110 - TradingKey
YD Bio Ord Shs (YDES) Balance Sheet - TradingKey
YDES|YD Bio Ord Shs|Price:2.300|Chg%:-0.020 - TradingKey
YDESW Warrants Surge 19%: Testing Critical $0.30 ResistanceSize Factor - vinanet.vn
Yd Bio Ltd (YDES) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):